Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3422 | 1135 | 34.6 | 63% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
75 | 80922 | MUTATION RESEARCH//TOXICOLOGY//CARCINOGENESIS |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
12936 | 808 | ENVIRONMENTAL CIGARETTE SMOKE//STRAIN A J MICE//LUNG TUMORS |
28096 | 175 | AEROSOL DRUG ADMINISTRATION//ALMOND HARVEST//ALMOND HARVESTING |
33394 | 92 | HUMAN EXPOSURE CHAMBER//EXPOSURE CHAMBER//CHLORONITROMETHANE |
34871 | 60 | NASAL AIRFLOW//SAUL A SILVERMAN FAMILY FDN//VA1 RNA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ENVIRONMENTAL CIGARETTE SMOKE | Author keyword | 18 | 89% | 1% | 8 |
2 | STRAIN A J MICE | Author keyword | 8 | 75% | 1% | 6 |
3 | LUNG TUMORS | Author keyword | 5 | 14% | 3% | 34 |
4 | UV CONTAINING LIGHT | Author keyword | 3 | 100% | 0% | 3 |
5 | TUMOR SUSCEPTIBILITY GENES | Author keyword | 3 | 60% | 0% | 3 |
6 | SECT HYG PREVENT MED | Address | 3 | 24% | 1% | 9 |
7 | IMUNOGENET | Address | 2 | 13% | 2% | 18 |
8 | RECOMBINANT CONGENIC STRAINS | Author keyword | 2 | 36% | 0% | 5 |
9 | CANCER MODIFIER GENES | Author keyword | 2 | 67% | 0% | 2 |
10 | CHEM MUTAGENESIS CARCINOGENESIS | Address | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INDUCED PULMONARY ADENOMAS | 26 | 87% | 1% | 13 |
2 | LUNG TUMOR SUSCEPTIBILITY | 23 | 74% | 1% | 17 |
3 | ADENOMA RESISTANCE LOCUS | 21 | 90% | 1% | 9 |
4 | AEROSOLIZED BUDESONIDE | 19 | 68% | 1% | 17 |
5 | PAS1 LOCUS | 15 | 77% | 1% | 10 |
6 | FEMALE A J MICE | 14 | 47% | 2% | 22 |
7 | KRAS2 | 12 | 75% | 1% | 9 |
8 | CLARA CELL ADENOMA | 11 | 67% | 1% | 10 |
9 | RECOMBINANT CONGENIC STRAINS | 11 | 29% | 3% | 32 |
10 | TUMOR SUSCEPTIBILITY | 11 | 34% | 2% | 26 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Classification of proliferative pulmonary lesions of the mouse: Recommendations of the mouse models of human cancers consortium | 2004 | 171 | 60 | 42% |
Rationale and Approaches to the Prevention of Smoking-Related Diseases: Overview of Recent Studies on Chemoprevention of Smoking-Induced Tumors in Rodent Models | 2014 | 1 | 29 | 59% |
Cancer susceptibility in the mouse: Genetics, biology and implications for human cancer | 2003 | 103 | 106 | 38% |
Mouse models for human lung cancer | 2005 | 140 | 226 | 19% |
The Kras2 oncogene and mouse lung carcinogenesis | 2008 | 5 | 35 | 60% |
A further review of inhalation studies with cigarette smoke and lung cancer in experimental animals, including transgenic mice | 2010 | 11 | 63 | 52% |
Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers | 2009 | 31 | 131 | 21% |
Mouse lung epithelial cell lines - tools for the study of differentiation and the neoplastic phenotype | 1997 | 82 | 127 | 34% |
Modeling human lung cancer in mice: similarities and shortcomings | 1999 | 68 | 92 | 24% |
Transplacental Antioxidants Inhibit Lung Tumors in Mice Exposed to Cigarette Smoke After Birth: A Novel Preventative Strategy? | 2012 | 8 | 37 | 27% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SECT HYG PREVENT MED | 3 | 24% | 0.8% | 9 |
2 | IMUNOGENET | 2 | 13% | 1.6% | 18 |
3 | CHEM MUTAGENESIS CARCINOGENESIS | 2 | 67% | 0.2% | 2 |
4 | MCGILL COMPLEX TRAITS GRP | 2 | 67% | 0.2% | 2 |
5 | CHEMOPREVENT BRANCH | 2 | 12% | 1.2% | 14 |
6 | ANIM DIS MODEL | 1 | 100% | 0.2% | 2 |
7 | COLORADO CANC PHARMACEUT SCI | 1 | 100% | 0.2% | 2 |
8 | PREDICT PREVENT MED | 1 | 18% | 0.6% | 7 |
9 | MOL GENET H5 | 1 | 40% | 0.2% | 2 |
10 | PROTECT MAN ECOSYST | 1 | 40% | 0.2% | 2 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000019589 | ORTHO PHENYLPHENOL//SEX DISCRIMINATION OF CANCER RISK//HEPATOCARCINOGENESIS |
2 | 0.0000016076 | CELL TRANSFORMATION ASSAY//ONCOGENIC RAS P21//BHAS 42 CELLS |
3 | 0.0000011051 | 1 HYDROXYPYRENE//POLYCYCLIC AROMATIC HYDROCARBONS//DNA ADDUCTS |
4 | 0.0000009139 | ALPHA1 ANTITRYPSIN DEFICIENCY//ALPHA 1 ANTITRYPSIN//EMPHYSEMA |
5 | 0.0000008605 | TOXICOGENOMICS//BENCHMARK DOSE//GENOTOXIC IMPURITIES |
6 | 0.0000008274 | LUNG CANCER//THORAC SURG//TRANSBRONCHIAL NEEDLE ASPIRATION |
7 | 0.0000007917 | IMMUNOTOXICITY//DEVELOPMENTAL IMMUNOTOXICITY//TGN1412 |
8 | 0.0000007116 | ASBESTOS//CROCIDOLITE//CHRYSOTILE |
9 | 0.0000006905 | FARNESYLTRANSFERASE//PALMITOYLATION//RLIP76 |
10 | 0.0000006864 | RBM5//MEIOTIC DRIVE//HUMAN CHROMOSOME 3 |